Double-blind, placebo-controlled phase 1 trial of nizaracianine administered in three divided doses to healthy volunteers

Authors
Category Primary study
ConferenceMolecular imaging and biology
Year 2025
This article has no abstract
Epistemonikos ID: 8fc762aceffee8ce7f1a3cfc76cd6eb8d70a9f5a
First added on: Feb 14, 2026